Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Emerging mechanisms and targeted therapy of ferroptosis in neurological diseases and neuro-oncology
The percentage of patients receiving GLP-1 medications both before and after bariatric surgery also showed steady growth, rising from 0.5% in 2018 to 3.3% in 2023, calling into question the extent to which GLP-1s are a replacement versus a supplemental therapy
Based on these data, across all studies, few participants received rescue therapy (ranging approximately between 0.3% and 3.5% of participants), except for one study in which 25% of participants in the placebo arm required rescue therapy [22]
Diabetes Obes Metab agosto de
Life-changing for me
Synergistic multi-modal strategy : Integrates brachytherapy with chemotherapy, immunotherapy, and nanoparticle-based radiosensitizers for enhanced tumor control
